{"id":"https://openalex.org/W2022096337","doi":"https://doi.org/10.1007/s13300-013-0024-0","title":"Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies","display_name":"Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies","alternate_titles":[],"publication_year":2013,"publication_date":"2013-05-22","ids":{"openalex":"https://openalex.org/W2022096337","doi":"https://doi.org/10.1007/s13300-013-0024-0","mag":"2022096337","pmid":"https://pubmed.ncbi.nlm.nih.gov/23700194","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3687098"},"language":"en","primary_location":{"id":"doi:10.1007/s13300-013-0024-0","doi":"https://doi.org/10.1007/s13300-013-0024-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-013-0024-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0024-0.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2022096337"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0024-0.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031476174","display_name":"Samuel S. Engel","orcid":"https://orcid.org/0000-0002-4439-6356","observed_orcids":["https://orcid.org/0000-0002-4439-6356"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Samuel S. Engel","raw_affiliation_strings":["Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA, samuel.engel@merck.com","Merck Sharp and Dohme Corp, Whitehouse Station, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA, samuel.engel@merck.com","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck Sharp and Dohme Corp, Whitehouse Station, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082927548","display_name":"Elizabeth Round","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Round","raw_affiliation_strings":["Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA","Merck Sharp and Dohme Corp, Whitehouse Station, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck Sharp and Dohme Corp, Whitehouse Station, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021756822","display_name":"Gregory T. Golm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory T. Golm","raw_affiliation_strings":["Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA","Merck Sharp and Dohme Corp, Whitehouse Station, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck Sharp and Dohme Corp, Whitehouse Station, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027357772","display_name":"Keith D. Kaufman","orcid":"https://orcid.org/0000-0002-9919-9915","observed_orcids":["https://orcid.org/0000-0002-9919-9915"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith D. Kaufman","raw_affiliation_strings":["Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA","Merck Sharp and Dohme Corp, Whitehouse Station, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck Sharp and Dohme Corp, Whitehouse Station, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108471022","display_name":"Barry J. Goldstein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry J. Goldstein","raw_affiliation_strings":["Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA","Merck Sharp and Dohme Corp, Whitehouse Station, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck Sharp and Dohme Corp, Whitehouse Station, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031476174"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":12.0242,"has_fulltext":true,"cited_by_count":135,"citation_normalized_percentile":{"value":0.9913659,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":100},"biblio":{"volume":"4","issue":"1","first_page":"119","last_page":"145"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.984000027179718},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9589999914169312},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9110000133514404},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.9599999785423279},{"id":"https://openalex.org/keywords/drug-related-adverse-events","display_name":"drug-related adverse events","score":0.8069999814033508},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.847000002861023},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.7990000247955322},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.5320000052452087},{"id":"https://openalex.org/keywords/constipation","display_name":"constipation","score":0.9810000061988831},{"id":"https://openalex.org/keywords/pancreatitis","display_name":"pancreatitis","score":0.7400000095367432},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.8629999756813049},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.7020000219345093},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.7519999742507935},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.6840000152587891},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.7429999709129333},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.9900006651878357},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9045792818069458},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8554834127426147},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.8395041227340698},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8116918802261353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6046209931373596},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5833271145820618},{"id":"https://openalex.org/C2778763485","wikidata":"https://www.wikidata.org/wiki/Q419770","display_name":"Dipeptidyl peptidase-4 inhibitor","level":4,"score":0.5020513534545898},{"id":"https://openalex.org/C2910260750","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin Phosphate","level":5,"score":0.4923919439315796},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47948893904685974},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4779398739337921},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4716714322566986},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44011250138282776},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.26930534839630127},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.22011658549308777}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1007/s13300-013-0024-0","doi":"https://doi.org/10.1007/s13300-013-0024-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-013-0024-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0024-0.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2682647","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3687098","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:23700194","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23700194","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes therapy : research, treatment and education of diabetes and related disorders","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3687098","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3687098/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Ther","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.948.6160","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.948.6160","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://europepmc.org/backend/ptpmcrender.fcgi?accid%3DPMC3687098%26blobtype%3Dpdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1007/s13300-013-0024-0","doi":"https://doi.org/10.1007/s13300-013-0024-0","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-013-0024-0","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0024-0.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2022096337.pdf","grobid_xml":"https://content.openalex.org/works/W2022096337.grobid-xml"},"referenced_works_count":78,"referenced_works":["https://openalex.org/W40400977","https://openalex.org/W76204639","https://openalex.org/W1520153559","https://openalex.org/W1546635462","https://openalex.org/W1547073044","https://openalex.org/W1585447752","https://openalex.org/W1589782664","https://openalex.org/W1865765771","https://openalex.org/W1945276862","https://openalex.org/W1965873026","https://openalex.org/W1966469183","https://openalex.org/W1970638723","https://openalex.org/W1976425553","https://openalex.org/W1986085856","https://openalex.org/W1994832750","https://openalex.org/W2014000186","https://openalex.org/W2016565181","https://openalex.org/W2018192866","https://openalex.org/W2019932241","https://openalex.org/W2029214914","https://openalex.org/W2029907219","https://openalex.org/W2031848004","https://openalex.org/W2033072177","https://openalex.org/W2033316662","https://openalex.org/W2038953694","https://openalex.org/W2040643300","https://openalex.org/W2046381181","https://openalex.org/W2051462052","https://openalex.org/W2055753691","https://openalex.org/W2060537172","https://openalex.org/W2065582045","https://openalex.org/W2067073421","https://openalex.org/W2067736115","https://openalex.org/W2075182875","https://openalex.org/W2084744936","https://openalex.org/W2085862152","https://openalex.org/W2087025850","https://openalex.org/W2088023073","https://openalex.org/W2095682936","https://openalex.org/W2099707525","https://openalex.org/W2101246901","https://openalex.org/W2102511839","https://openalex.org/W2104079863","https://openalex.org/W2107992917","https://openalex.org/W2108292236","https://openalex.org/W2108633856","https://openalex.org/W2111876001","https://openalex.org/W2112981414","https://openalex.org/W2113901579","https://openalex.org/W2121162069","https://openalex.org/W2122633654","https://openalex.org/W2129578585","https://openalex.org/W2131505599","https://openalex.org/W2133034433","https://openalex.org/W2134250131","https://openalex.org/W2136259411","https://openalex.org/W2138801798","https://openalex.org/W2139562487","https://openalex.org/W2141848583","https://openalex.org/W2145335273","https://openalex.org/W2145777529","https://openalex.org/W2146901298","https://openalex.org/W2150849997","https://openalex.org/W2155161532","https://openalex.org/W2158727328","https://openalex.org/W2164535707","https://openalex.org/W2166173635","https://openalex.org/W2171512247","https://openalex.org/W2171667655","https://openalex.org/W2172193326","https://openalex.org/W2249586559","https://openalex.org/W2325963726","https://openalex.org/W2553676783","https://openalex.org/W2724744060","https://openalex.org/W2781184586","https://openalex.org/W3085323863","https://openalex.org/W4205303953","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2150849997","https://openalex.org/W2040643300","https://openalex.org/W1995566056","https://openalex.org/W197747024","https://openalex.org/W2108292236","https://openalex.org/W2181940024","https://openalex.org/W2359196108","https://openalex.org/W2378900780"],"abstract_inverted_index":{"INTRODUCTION:":[0],"In":[1,301],"a":[2,106,182,260],"previous":[3],"pooled":[4,73,304],"analysis":[5,62,83,306],"of":[6,19,69,133,151,211,219,237,252,259,269,276,292,307,324],"19":[7],"double-blind":[8,77,119],"clinical":[9,49,78,131,322],"studies":[10,54,91,115,155],"conducted":[11,121],"by":[12,71,122],"Merck,":[13],"which":[14,146],"included":[15,84,125],"data":[16,74,85,196,308],"available":[17,149],"as":[18,150,162,172],"July":[20],"2009":[21],"on":[22],"10,246":[23],"patients":[24,88,126,311],"with":[25,31,41,43,55,92,128,167,176,231,283,288,312],"type":[26],"2":[27,142,327],"diabetes":[28],"(T2DM),":[29],"treatment":[30,42],"sitagliptin":[32,48,56,70,97,103,134,233,280,284,314],"was":[33,285,317],"shown":[34],"to":[35,202,255,265,326],"be":[36],"generally":[37,241,318],"well":[38,319],"tolerated":[39,320],"compared":[40,230],"control":[44],"agents.":[45],"As":[46],"the":[47,64,129,207,227,232,244,256,266,272,279],"development":[50],"program":[51],"continues,":[52],"additional":[53],"have":[57],"been":[58],"completed.":[59],"The":[60,81],"present":[61,82],"updates":[63],"safety":[65,305],"and":[66,141,144,221,262,275],"tolerability":[67],"assessment":[68],"examining":[72],"from":[75,86,197,309],"25":[76,90],"studies.":[79],"METHODS:":[80],"14,611":[87,310],"in":[89,206,226,271,278,321,329],"T2DM":[93],"who":[94],"received":[95],"either":[96],"100":[98,315],"mg/day":[99,316],"(n":[100,109],"=":[101,110],"7,726;":[102],"group)":[104],"or":[105,169,171,189,193,298],"comparator":[107,159],"agent":[108],"6,885;":[111],"non-exposed":[112,228,273],"group).":[113],"These":[114,154],"represent":[116],"all":[117],"randomized,":[118],"trials":[120,323],"Merck":[123],"that":[124],"treated":[127],"usual":[130],"dose":[132],"(100":[135],"mg/day)":[136],"for":[137,145,248],"between":[138,243],"12":[139],"weeks":[140],"years,":[143],"results":[147],"were":[148,200,224,240],"December":[152],"2011.":[153],"assessed":[156],"sitagliptin,":[157],"versus":[158],"agents,":[160],"taken":[161],"monotherapy,":[163],"initial":[164],"combination":[165,174],"therapy":[166,175],"metformin":[168,190,270],"pioglitazone,":[170,181],"add-on":[173],"other":[177],"antihyperglycemic":[178],"agents":[179],"(metformin,":[180],"sulfonylurea":[183,261],"\u00b1":[184,187],"metformin,":[185,188],"insulin":[186],"+":[191],"pioglitazone":[192],"rosiglitazone).":[194],"Patient-level":[195],"each":[198],"study":[199],"used":[201],"evaluate":[203],"between-group":[204],"differences":[205],"exposure-adjusted":[208],"incidence":[209,217,250],"rates":[210,218,236,251],"adverse":[212,294],"events":[213],"(AEs).":[214],"RESULTS:":[215],"Overall":[216],"AEs":[220,223,239],"drug-related":[222],"higher":[225,249],"group":[229],"group.":[234,281],"Incidence":[235],"specific":[238],"similar":[242],"two":[245],"groups,":[246],"except":[247],"hypoglycemia":[253],"related":[254,264],"greater":[257,267],"use":[258,268],"diarrhea":[263],"group,":[274],"constipation":[277],"Treatment":[282],"not":[286],"associated":[287],"an":[289],"increased":[290],"risk":[291],"major":[293],"cardiovascular":[295],"events,":[296],"malignancy,":[297],"pancreatitis.":[299],"CONCLUSION:":[300],"this":[302],"updated":[303],"T2DM,":[313],"up":[325],"years":[328],"duration.":[330]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2022096337","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":32},{"year":2014,"cited_by_count":15},{"year":2013,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
